| Literature DB >> 21695270 |
Pedro Marques-Vidal1, Murielle Bochud, François Bastardot, Thomas Lüscher, François Ferrero, Jean-Michel Gaspoz, Fred Paccaud, Adrian Urwyler, Roland von Känel, Christoph Hock, Gérard Waeber, Martin Preisig, Peter Vollenweider.
Abstract
OBJECTIVE: to assess the levels and determinants of interleukin (IL)-1β, IL-6, tumour necrosis factor (TNF)-α and C-reactive protein (CRP) in a healthy Caucasian population.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21695270 PMCID: PMC3111463 DOI: 10.1371/journal.pone.0021002
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Interleukin-1β distribution according to different parameters.
| All | Dosable | Median,pg/ml | % below | % in quartile | ||||
| N | N | (IQR) | LOD | 1 | 2 | 3 | 4 | |
| All subjects | 6085 | 3796 | 1.17(0.48–3.90) | 37.6 | 37.6 | 20.7 | 20.5 | 21.2 |
| Sex | ||||||||
| Men | 2884 | 1746 | 1.08(0.45–3.96) | 39.5 | 39.5 | 21.7 | 18.9 | 20.0 |
| Women | 3201 | 2050 | 1.28(0.52–3.79) | 36.0 | 36.0 | 19.8 | 22.0 | 22.2 |
| Test | 4.33 | 7.93 | 18.37 | |||||
| Age group (years) | ||||||||
| [35–44] | 1714 | 1172 | 1.32(0.54–4.30) | 31.6 | 31.6 | 20.8 | 22.6 | 25.0 |
| [45–54] | 1734 | 1103 | 1.26(0.48–3.98) | 36.4 | 36.4 | 20.7 | 20.3 | 22.6 |
| [55–64] | 1677 | 1007 | 1.02(0.44–3.27) | 40.0 | 40.0 | 21.7 | 20.2 | 18.2 |
| [65–75] | 960 | 514 | 1.13(0.45–3.55) | 46.5 | 46.5 | 18.9 | 17.7 | 17.0 |
| Test | 14.61 | 63.24 | 77.72 | |||||
| BMI categories | ||||||||
| Normal | 2925 | 1874 | 1.32(0.53–4.09) | 35.9 | 35.9 | 19.3 | 22.0 | 22.8 |
| Overweight | 2222 | 1357 | 1.06(0.45–3.90) | 38.9 | 38.9 | 22.2 | 18.5 | 20.3 |
| Obese | 938 | 565 | 1.03(0.45–2.91) | 39.8 | 39.8 | 21.4 | 20.8 | 18.0 |
| Test | 10.35 | 7.02 | 26.21 | |||||
| Smoking status | ||||||||
| Never | 2445 | 1536 | 1.17(0.51–3.70) | 37.2 | 37.2 | 20.2 | 21.7 | 20.9 |
| Former | 2009 | 1229 | 1.10(0.45–3.82) | 38.8 | 38.8 | 21.7 | 19.2 | 20.3 |
| Current | 1631 | 1031 | 1.27(0.49–4.46) | 36.8 | 36.8 | 20.2 | 20.4 | 22.6 |
| Test | 4.49 | 1.93 | 8.57 | |||||
| Leisure-time PA | ||||||||
| No | 2156 | 1369 | 1.19(0.47–3.82) | 36.5 | 36.5 | 21.0 | 21.6 | 20.9 |
| Yes | 3929 | 2427 | 1.17(0.49–3.93) | 38.2 | 38.2 | 20.5 | 20.0 | 21.3 |
| Test | 0.01 | 1.77 | 3.13 | |||||
Results are expressed as median and (interquartile range, IQR) for values over detection level, and as % (all subjects). BMI, body mass index; CVD, cardiovascular disease; LOD, limits of detection; PA, physical activity. Statistical analysis by Kruskall-Wallis nonparametric test (for medians) and by chi-square (for percentages):
, not significant;
*, p<0.05;
**, p<0.01;
***, p<0.001.
Interleukin-6 distribution according to different parameters.
| All | Dosable | Median,pg/ml | % below | % in quartile | ||||
| N | N | (IQR) | LOD | 1 | 2 | 3 | 4 | |
| All subjects | 6085 | 5634 | 1.47(0.71–3.53) | 7.4 | 25.1 | 24.8 | 25.1 | 25.0 |
| Sex | ||||||||
| Men | 2884 | 2697 | 1.59(0.77–3.84) | 6.5 | 22.3 | 24.4 | 26.0 | 27.3 |
| Women | 3201 | 2937 | 1.37(0.67–3.23) | 8.2 | 27.5 | 25.1 | 24.4 | 23.0 |
| Test | 19.62 | 6.87 | 29.17 | |||||
| Age group (years) | ||||||||
| [35–44] | 1714 | 1550 | 1.38(0.65–3.51) | 9.6 | 29.5 | 23.6 | 22.6 | 24.3 |
| [45–54] | 1734 | 1594 | 1.41(0.69–3.54) | 8.1 | 26.2 | 25.6 | 23.3 | 24.9 |
| [55–64] | 1677 | 1579 | 1.52(0.71–3.40) | 5.8 | 23.8 | 25.0 | 26.3 | 24.9 |
| [65–75] | 960 | 911 | 1.70(0.90–3.68) | 5.1 | 17.3 | 24.9 | 30.8 | 27.0 |
| Test | 18.36 | 26.18 | 61.68 | |||||
| BMI categories | ||||||||
| Normal | 2925 | 2652 | 1.36(0.64–3.46) | 9.3 | 29.6 | 24.0 | 22.3 | 24.1 |
| Overweight | 2222 | 2075 | 1.45(0.73–3.37) | 6.6 | 23.8 | 26.2 | 25.7 | 24.4 |
| Obese | 938 | 907 | 1.96(0.99–4.04) | 3.3 | 14.1 | 23.6 | 32.6 | 29.7 |
| Test | 47.58 | 40.85 | 113.74 | |||||
| Smoking status | ||||||||
| Never | 2445 | 2235 | 1.32(0.65–3.11) | 8.6 | 28.6 | 25.6 | 23.7 | 22.1 |
| Former | 2009 | 1853 | 1.50(0.71–3.61) | 7.8 | 25.6 | 24.4 | 24.6 | 25.4 |
| Current | 1631 | 1546 | 1.73(0.86–4.06) | 5.2 | 19.2 | 24.0 | 27.8 | 29.0 |
| Test | 39.69 | 16.81 | 61.20 | |||||
| Leisure-time PA | ||||||||
| No | 2156 | 2027 | 1.63(0.77–3.68) | 6.0 | 22.0 | 24.2 | 27.3 | 26.5 |
| Yes | 3929 | 3607 | 1.41(0.69–3.42) | 8.2 | 26.7 | 25.1 | 23.9 | 24.3 |
| Test | 11.03 | 9.93 | 21.86 | |||||
Results are expressed as median and (interquartile range, IQR) for values over detection level, and as % (all subjects). BMI, body mass index; CVD, cardiovascular disease; LOD, limits of detection; PA, physical activity. Statistical analysis by Kruskall-Wallis nonparametric test (for medians) and by chi-square (for percentages):
**, p<0.01;
***, p<0.001.
Tumor Necrosis Factor-α distribution according to different parameters.
| All | Dosable | Median,pg/ml | % below | % in quartile | ||||
| N | N | (IQR) | LOD | 1 | 2 | 3 | 4 | |
| All subjects | 6085 | 6042 | 2.89(1.82–4.53) | 0.7 | 25.2 | 24.7 | 25.2 | 24.9 |
| Sex | ||||||||
| Men | 2884 | 2865 | 3.05(1.90–4.65) | 0.7 | 23.1 | 23.9 | 27.1 | 26.0 |
| Women | 3201 | 3177 | 2.75(1.73–4.42) | 0.7 | 27.2 | 25.5 | 23.4 | 23.9 |
| Test | 22.59 | 0.18 | 22.89 | |||||
| Age group (years) | ||||||||
| [35–44] | 1714 | 1701 | 2.59(1.66–4.08) | 0.8 | 29.7 | 27.3 | 22.0 | 21.1 |
| [45–54] | 1734 | 1719 | 2.87(1.76–4.44) | 0.9 | 26.9 | 23.8 | 25.3 | 24.0 |
| [55–64] | 1677 | 1667 | 3.04(1.94–4.63) | 0.6 | 22.5 | 24.3 | 27.4 | 25.8 |
| [65–75] | 960 | 955 | 3.31(2.11–5.18) | 0.5 | 19.1 | 22.6 | 26.8 | 31.6 |
| Test | 74.70 | 1.45 | 81.07 | |||||
| BMI categories | ||||||||
| Normal | 2925 | 2901 | 2.70(1.71–4.21) | 0.8 | 27.9 | 26.2 | 24.2 | 21.7 |
| Overweight | 2222 | 2209 | 2.97(1.85–4.61) | 0.6 | 24.5 | 23.8 | 25.8 | 25.9 |
| Obese | 938 | 932 | 3.41(2.13–5.27) | 0.6 | 18.7 | 22.5 | 26.8 | 32.1 |
| Test | 66.54 | 1.07 | 64.78 | |||||
| Smoking status | ||||||||
| Never | 2445 | 2430 | 2.79(1.76–4.42) | 0.6 | 26.5 | 25.9 | 24.1 | 23.4 |
| Former | 2009 | 1988 | 2.97(1.84–4.54) | 1.0 | 24.9 | 23.8 | 26.4 | 24.9 |
| Current | 1631 | 1624 | 3.00(1.87–4.80) | 0.4 | 23.7 | 24.0 | 25.3 | 27.0 |
| Test | 11.39 | 5.38 | 13.03 | |||||
| Leisure-time PA | ||||||||
| No | 2156 | 2140 | 2.99(1.85–4.76) | 0.7 | 25.0 | 23.1 | 25.1 | 26.9 |
| Yes | 3929 | 3902 | 2.85(1.81–4.45) | 0.7 | 25.4 | 25.6 | 25.3 | 23.8 |
| Test | 5.68 | 0.06 | 9.24 | |||||
Results are expressed as median and (interquartile range, IQR) for values over detection level, and as % (all subjects). BMI, body mass index; CVD, cardiovascular disease; LOD, limits of detection; PA, physical activity. Statistical analysis by Kruskall-Wallis nonparametric test (for medians) and by chi-square (for percentages):
, not significant;
*, p<0.05;
**, p<0.01;
***, p<0.001.
High sensitive-CRP distribution according to different parameters.
| All | Dosable | Median,pg/ml | % in quartile | ||||
| N | N | (IQR) | 1 | 2 | 3 | 4 | |
| All subjects | 6085 | 6084 | 1.3 (0.6–2.7) | 21.9 | 29.8 | 22.4 | 25.8 |
| Sex | |||||||
| Men | 2884 | 2883 | 1.2 (0.6–2.6) | 22.0 | 31.1 | 23.3 | 23.6 |
| Women | 3201 | 3201 | 1.3 (0.6–2.9) | 21.9 | 28.7 | 21.6 | 27.8 |
| Test | 6.16 | 15.15 | |||||
| Age group (years) | |||||||
| [35–44] | 1714 | 1713 | 1.0 (0.4–2.2) | 31.3 | 29.9 | 17.3 | 21.5 |
| [45–54] | 1734 | 1734 | 1.1 (0.6–2.4) | 24.0 | 32.8 | 20.9 | 22.3 |
| [55–64] | 1677 | 1677 | 1.5 (0.7–3.1) | 15.5 | 29.6 | 25.3 | 29.5 |
| [65–75] | 960 | 960 | 1.8 (0.9–3.4) | 12.6 | 24.8 | 29.2 | 33.4 |
| Test | 226.8 | 254.3 | |||||
| BMI categories | |||||||
| Normal | 2925 | 2924 | 0.8 (0.4–1.7) | 33.9 | 33.8 | 17.7 | 14.6 |
| Overweight | 2222 | 2222 | 1.6 (0.8–3.1) | 13.4 | 30.4 | 26.6 | 29.6 |
| Obese | 938 | 938 | 2.8 (1.5–5.5) | 4.9 | 16.2 | 27.1 | 51.8 |
| Test | 929.2 | 916.2 | |||||
| Smoking status | |||||||
| Never | 2445 | 2445 | 1.2 (0.6–2.6) | 23.0 | 30.5 | 21.6 | 24.8 |
| Former | 2009 | 2009 | 1.3 (0.6–2.7) | 21.9 | 30.1 | 22.8 | 25.3 |
| Current | 1631 | 1630 | 1.4 (0.7–2.9) | 20.4 | 28.5 | 23.2 | 28.0 |
| Test | 13.6 | 9.81 | |||||
| Leisure-time PA | |||||||
| No | 2156 | 2156 | 1.6 (0.7–3.5) | 16.6 | 27.0 | 24.4 | 32.0 |
| Yes | 3929 | 3928 | 1.1 (0.6–2.4) | 24.8 | 31.4 | 21.4 | 22.4 |
| Test | 119.88 | 106.94 | |||||
Results are expressed as median and (interquartile range, IQR) for values over detection level, and as % (all subjects). BMI, body mass index; CVD, cardiovascular disease; LOD, limits of detection; PA, physical activity. Statistical analysis by Kruskall-Wallis nonparametric test (for medians) and by chi-square (for percentages):
, not significant;
**, p<0.01;
***, p<0.001.
Multivariate linear regression using log-transformed values of cytokines.
| IL-1β | IL-6 | TNF-α | CRP | |
| Men(yes vs. no) | −0.0638(0.0495) | 0.0756(0.0366) | 0.0517(0.0228) | −0.2210(0.0261) |
| Age | −0.0077(0.0023) | 0.0029(0.0017) | 0.0071(0.0011) | 0.0128(0.0012) |
| BMI | −0.0074(0.0055) | 0.0224(0.0041) | 0.0163(0.0026) | 0.0969(0.0029) |
| Former smoker(yes vs. no) | 0.0080(0.0572) | 0.0965(0.0425) | 0.0297(0.0264) | −0.0030(0.0301) |
| Current smoker(yes vs. no) | 0.1118(0.0605) | 0.2524(0.0450) | 0.1165(0.0280) | 0.2327(0.0321) |
| Leisure-time PA(yes vs. no) | −0.0035(0.0512) | −0.0276(0.0378) | −0.0063(0.0236) | −0.1520(0.0270) |
Results are expressed as slope and (standard error). BMI, body mass index; hs-CRP, high sensitive C reactive protein; IL-1β, interleukin-1β; IL-6, interleukin-6; PA, physical activity; TNF-α, tumor necrosis factor-α. Statistical analysis by linear regression on log-transformed cytokine values:
*, p<0.05;
***, p<0.001.